Letter: Continuous administration of dilantin.
D002648:Child; D004077:Digoxin / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D010672:Phenytoin / Q000008:administration & dosage / Q000627:therapeutic use*
D010672:Phenytoin; D004077:Digoxin